MiniMed Group MMED Italy — Accrued rebates, noncurrent
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by MiniMed Group in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerRefundLiabilityNoncurrent.
The source filing: MiniMed Group’s 10-Q, filed April 17, 2026.
- Filed
- Apr 17, 2026, 4:29 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-025777
At January 23, 2026, $48 million of rebates and other adjustments were classified as accrued rebates and $48 million of rebates and other adjustments were classified as other liabilities in the condensed combined balance sheets. At April 25, 2025, $51 million of rebates and other adjustments were classified as accrued rebates and $38 million of rebates and other adjustments were classified as other liabilities in the condensed combined balance sheets. There was $7 million and $5 million of return reserves classified as other accrued expenses in the condensed combined balance sheets at January 23, 2026 and April 25, 2025, respectively.
Item 1. Financial Statements (
FAQ
- What is MiniMed Group's italy — accrued rebates, noncurrent?
- MiniMed Group (MMED) reported italy — accrued rebates, noncurrent of $48M in Q1 2026.
- What does italy — accrued rebates, noncurrent mean?
- This represents the long-term portion of estimated rebates owed to healthcare providers, distributors, or government entities in Italy for medical device sales. It captures future financial obligations that extend beyond the next fiscal year, often related to volume-based incentives or long-term pricing agreements. Tracking this provides insight into the company's long-term pricing strategy and potential future cash outflows.
Ask your AI about MiniMed Group's italy — accrued rebates, noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
